Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech Announces Clinical Supply Agreement To Evaluate Pelareorep In Combination With Loqtorzi In Squamous Cell Anal Carcinoma

BRIEF-Oncolytics Biotech Announces Clinical Supply Agreement To Evaluate Pelareorep In Combination With Loqtorzi In Squamous Cell Anal Carcinoma

- Oncolytics Biotech Inc ONCY.O:

  • ONCOLYTICS BIOTECH® ANNOUNCES CLINICAL SUPPLY AGREEMENT TO EVALUATE PELAREOREP IN COMBINATION WITH LOQTORZI® (TORIPALIMAB-TPZI) IN SQUAMOUS CELL ANAL CARCINOMA

  • ONCOLYTICS BIOTECH - STUDY EXPECTED TO BEGIN IN THE U.S. IN Q1 2027

Source text: ID:nGNX5hymWH

Further company coverage: ONCY.O


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Oncolytics Biotech

See all news